Case series report: Early cement-implant interface fixation failure in total knee replacement

The Knee
Kyle J HazelwoodWilliam J Robb

Abstract

Early failure in cemented total knee replacement (TKR) due to aseptic loosening is uncommon. A small number of early failures requiring revision were observed at one hospital due to observed cement-implant fixation failure. The purpose of this case series is to report and identify possible causes for these early failures. Between May 2005 and December 2010, 3048 primary TKRs were performed over a five-year period of time by six surgeons. Two total knee systems were used during this period of time. Nine early failures were observed in eight patients. High viscosity cement (HVC) was used in all these cases. Aseptic loosening of the tibial component was observed in all nine early total knee failures. The high viscosity bone cement was noted to be non-adherent to the tibial trays at the time of revision surgery. HVC was used in all these cases. Properties of HVC may contribute to make it more susceptible to early failure in a small number of TKRs. HVC in total hip replacement (THR) has been associated with cement micro-fractures, cement debris generation and early implant failure. The mechanical properties of HVC may similarly contribute to early failure at the cement-implant interface in a small percentage TKRs.

References

Apr 1, 1984·Journal of Biomedical Materials Research·S Saha, S Pal
Sep 1, 1996·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J J StoneK N An
May 9, 2001·The Journal of Bone and Joint Surgery. British Volume·M J DunbarL Lidgren
Jan 5, 2002·Journal of Biomedical Materials Research·B P Murphy, P J Prendergast
Jul 26, 2005·Biomaterials·Michael D RiesLisa Pruitt
May 3, 2006·The Journal of Bone and Joint Surgery. American Volume·V J RasquinhaJ A Rodriguez
Apr 4, 2007·The Journal of Bone and Joint Surgery. American Volume·Steven KurtzMichael Halpern
Dec 17, 2008·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Sérgio Rocha PiedadePhilippe Neyret

❮ Previous
Next ❯

Citations

Feb 8, 2016·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Khaled J SalehThomas M Grupp
Sep 21, 2016·Clinical Orthopaedics and Related Research·David J Backstein
Nov 9, 2016·The Knee·J P van der ListA D Pearle
Jan 9, 2019·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Panagiotis TouzopoulosGeorgios I Drosos
Apr 19, 2019·Bone & Joint Research·A CerquigliniA J Hart
Jun 7, 2020·Journal of Experimental Orthopaedics·David LionbergerTimothy J Walker
Sep 24, 2018·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Kevin StaatsReinhard Windhager
Nov 25, 2018·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·ShiZhong GuShuichi Matsuda
Feb 22, 2021·The Journal of Arthroplasty·Ronald W B WyattHeather A Prentice
Feb 27, 2021·The Journal of Arthroplasty·Elise K LaendeMichael J Dunbar
Mar 8, 2021·The Journal of Arthroplasty·J Ryan MartinThomas K Fehring
Apr 9, 2021·The Journal of the American Academy of Orthopaedic Surgeons·Luke G MenkenJose A Rodriguez
Sep 11, 2021·Archives of Orthopaedic and Trauma Surgery·Andreas FuchsLukas Konstantinidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.